陈雯雯,王华

• 1:四川大学华西医院心内科

摘要(Abstract)：

冠心病患者行非心脏手术时具有较高的不良心血管事件发生风险，是影响患者预后的重要因素，加强冠心病患者围术期冠状动脉缺血风险识别与管理可以减少患者围术期并发症发生风险。现有评估冠状动脉缺血风险策略各具特点，对冠心病患者进行非心脏手术前缺血风险评估时，应综合患者特点、非心脏手术相关风险、各项检查手段适用范围，选择合适的冠状动脉缺血风险评估策略。对于非心脏手术前是否需要进行冠状动脉血运重建及采用何种血运重建策略，应综合患者临床特点、冠状动脉缺血风险、非心脏手术风险，多学科讨论后决定是否进行血运重建及选择适宜的血运重建方式。本文就冠心病患者非心脏手术围术期风险因素、术前冠状动脉缺血风险评估手段及血运重建策略与选择进行阐述。

关键词(KeyWords)： 冠心病;非心脏手术;血运重建

Abstract:

Keywords:

基金项目(Foundation):

作者(Author): 陈雯雯,王华

参考文献(References)：

• [1]Smilowitz NR,Gupta N,Guo Y,et al.Trends in cardiovascular risk factor and disease prevalence in patients undergoing noncardiac surgery[J].Heart,2018,104(14):1180-1186.DOI:10.1136/heartjnl-2017-31239.
• [2]Smilowitz NR,Gupta N,Ramakrishna H,et al.Perioperative major adverse cardiovascular and cerebrovascular events associated with noncardiac surgery[J].JAMA Cardiol,2017,2(2):181-187.DOI:10.1001/jamacardio.2016.4792.
• [3]Devereaux PJ,Sessler DI.Cardiac complications in patients undergoing major noncardiac surgery[J].N Engl J Med,2015,373(23):2258-2269.DOI:10.1056/NEJMra1502824.
• [4]Eagle KA,Rihal CS,Mickel MC,et al.Cardiac risk of noncardiac surgery:influence of coronary disease and type of surgery in 3 368operations.CASS Investigators and University of Michigan Heart Care Program.Coronary artery surgery study[J].Circulation,1997,96(6):1882-1887.DOI:10.1161/01.cir.96.6.1882.
• [5]Roger VL,Ballard DJ,Hallett Jr JW,et al.Influence of coronary artery disease on morbidity and mortality after abdominal aortic aneurysmectomy:a population-based study,1971-1987[J].J Am Coll Cardiol,1989,14(5):1245-1252.DOI:10.1016/0735-1097(89)90423-3.
• [6]Guay J,Choi P,Suresh S,et al.Neuraxial blockade for the prevention of postoperative mortality and major morbidity:an overview of Cochrane systematic reviews[J].Cochrane Database Syst Rev,2014,2014(1):CD010108.DOI:10.1002/14651858.CD010108.pub2.
• [7]Mangano DT.Perioperative medicine:NHLBI working group deliberations and recommendations[J].J Cardiothorac Vasc Anesth,2004,18(1):1-6.DOI:10.1053/j.jvca.2003.10.002.
• [8]Kristensen SD,Knuuti J,Saraste A,et al.2014 ESC/ESAguidelines on non-cardiac surgery:cardiovascular assessment and management:the joint task force on non-cardiac surgery:cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of Anaesthesiology (ESA)[J].Eur Heart J,2014,35(35):2383-2431.DOI:10.1093/eurheartj/ehu282.
• [9]Norderud K,Egholm G,Thim T,et al.Validation of the European Society of Cardiology and European Society of Anaesthesiology non-cardiac surgery risk score in patients treated with coronary drug-eluting stent implantation[J].Eur Heart J Qual Care Clin Outcomes,2019,5(1):22-27.DOI:10.1093/ehjqcco/qcy032.
• [10]Glance LG,Lustik SJ,Hannan EL,et al.The surgical mortality probability model:derivation and validation of a simple risk prediction rule for noncardiac surgery[J].Ann Surg,2012,255(4):696-702.DOI:10.1097/SLA.0b013e31824b45af.
• [11]Müller MD,Lyrer P,Brown MM,et al.Carotid artery stenting versus endarterectomy for treatment of carotid artery stenosis[J].Cochrane Database Syst Rev,2020,2(2):CD000515.DOI:10.1002/14651858.CD000515.pub5.
• [12]Bendixen M,J?rgensen OD,Kronborg C,et al.Postoperative pain and quality of life after lobectomy via video-assisted thoracoscopic surgery or anterolateral thoracotomy for early stage lung cancer:a randomised controlled trial[J].Lancet Oncol,2016,17(6):836-844.DOI:10.1016/S1470-2045(16)00173-X.
• [13]Falcoz PE,Puyraveau M,Thomas PA,et al.Video-assisted thoracoscopic surgery versus open lobectomy for primary non-smallcell lung cancer:a propensity-matched analysis of outcome from the European Society of Thoracic Surgeon database[J].Eur J Cardiothorac Surg,2016,49(2):602-609.DOI:10.1093/ejcts/ezv154.
• [14]Martin D,Mantziari S,Demartines N,et al.Defining major surgery:a Delphi consensus among European Surgical Association (ESA) Members[J].World J Surg,2020,44(7):2211-2219.DOI:10.1007/s00268-020-05476-4.
• [15]Bolliger M,Kroehnert JA,Molineus F,et al.Experiences with the standardized classification of surgical complications(Clavien-Dindo) in general surgery patients[J].Eur Surg,2018,50(6):256-261.DOI;10.1007/s10353-018-0551-z.
• [16]Boersma E,Poldermans D,Bax JJ,et al.Predictors of cardiac events after major vascular surgery:role of clinical characteristics,dobutamine echocardiography,and beta-blocker therapy[J].JAMA,2001,285(14):1865-1873.DOI:10.1001/jama.285.14.1865.
• [17]Jeger RV,Probst C,Arsenic R,et al.Long-term prognostic value of the preoperative 12-lead electrocardiogram before major noncardiac surgery in coronary artery disease[J].Am Heart J,2006,151(2):508-513.DOI:10.1016/j.ahj.2005.04.018.
• [18]Landesberg G,Einav S,Christopherson R,et al.Perioperative ischemia and cardiac complications in major vascular surgery:importance of the preoperative twelve-lead electrocardiogram[J].J Vasc Surg,1997,26(4):570-8.DOI:10.1016/s0741-5214(97)70054-5.
• [19]Halvorsen S,Mehilli J,Cassese S,et al.2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery[J].Eur Heart J,2022,43(39):3826-3924.DOI:10.1093/eurheartj/ehac270.
• [20]Kragelund C,Gr?nning B,K?ber L,et al.N-terminal pro-B-type natriuretic peptide and long-term mortality in stable coronary heart disease[J].N Engl J Med,2005,352(7):666-675.DOI:10.1056/NEJMoa042330.
• [21]Karthikeyan G,Moncur RA,Levine O,et al.Is a pre-operative brain natriuretic peptide or N-terminal pro-B-type natriuretic peptide measurement an independent predictor of adverse cardiovascular outcomes within 30 days of noncardiac surgery?A systematic review and Meta-analysis of observational studies[J].J Am Coll Cardiol,2009,54(17):1599-1606.DOI:10.1016/j.jacc.2009.06.028.
• [22]Rodseth RN,Lurati Buse GA,Bolliger D,et al.The predictive ability of pre-operative B-type natriuretic peptide in vascular patients for major adverse cardiac events:an individual patient data Meta-analysis[J].J Am Coll Cardiol,2011,58(5):522-529.DOI:10.1016/j.jacc.2011.04.018.
• [23]Duceppe E,Patel A,Chan MTV,et al.Preoperative N-terminal pro-B-type natriuretic peptide and cardiovascular events after noncardiac surgery:a cohort study[J].Ann Intern Med,2020,172(2):96-104.DOI:10.7326/M19-2501.
• [24]Weber M,Luchner A,Seeberger M,et al.Incremental value of high-sensitive troponin T in addition to the revised cardiac index for peri-operative risk stratifi cation in non-cardiac surgery[J].Eur Heart J,2013,34(11):853-862.DOI:10.1093/eurheartj/ehs445.
• [25]Hendel RC,Berman DS,Di Carli MF,et al.ACCF/ASNC/ACR/AHA/ASE/SCCT/SCMR/SNM 2009 appropriate use criteria for cardiac radionuclide imaging:a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force,the American Society of Nuclear Cardiology,the American College of Radiology,the American Heart Association,the American Society of Echocardiography,the Society of Cardiovascular Computed Tomography,the Society for Cardiovascular Magnetic Resonance,and the Society of Nuclear Medicine[J].Circulation,2009,119(22):e561-e587.DOI:10.1161/CIRCULATIONAHA.109.192519.
• [26]Ricci F,Khanji MY,Bisaccia G,et al.Diagnostic and prognostic value of stress cardiovascular magnetic resonance imaging in patients with known or suspected coronary artery disease:a systematic review and Meta-analysis[J].JAMA Cardiol,2023,8(7):662-673.DOI:10.1001/jamacardio.2023.1290.
• [27]Greenwood JP,Ripley DP,Berry C,et al.Effect of care guided by cardiovascular magnetic resonance,myocardial perfusion scintigraphy,or NICE guidelines on subsequent unnecessary angiography rates:the CE-MARC 2 randomized clinical trial[J].JAMA,2016,316(10):1051-1060.DOI:10.1001/jama.2016.12680.
• [28]Nagel E,Greenwood JP,Mccann GP,et al.Magnetic resonance perfusion or fractional flow reserve in coronary disease[J].N Engl JMed,2019,380(25):2418-2428.DOI:10.1056/NEJMoa1716734.
• [29]Pellikka PA,Arruda-Olson A,Chaudhry FA,et al.Guidelines for performance,interpretation,and application of stress echocardiography in ischemic heart disease:from the American Society of Echocardiography[J].J Am Soc Echocardiogr,2020,33(1):1-41.DOI:10.1016/j.echo.2019.07.001.
• [30]Shaw LJ,Berman DS,Picard MH,et al.Comparative defi nitions for moderate-severe ischemia in stress nuclear,echocardiography,and magnetic resonance imaging[J].JACC Cardiovasc Imaging,2014,7(6):593-604.DOI:10.1016/j.jcmg.2013.10.021.
• [31]Cullen MW,Mc Cully RB,Widmer RJ,et al.Preoperative dobutamine stress echocardiography and clinical factors for assessment of cardiac risk after noncardiac surgery[J].J Am Soc Echocardiogr,2020,33(4):423-432.DOI:10.1016/j.echo.2019.11.015.
• [32]Ballal RS,Kapadia S,Secknus MA,et al.Prognosis of patients with vascular disease after clinical evaluation and dobutamine stress echocardiography[J].Am Heart J,1999,137(3):469-475.DOI:10.1016/s0002-8703(99)70494-1.
• [33]Beattie WS,Abdelnaem E,Wijeysundera DN,et al.A Metaanalytic comparison of preoperative stress echocardiography and nuclear scintigraphy imaging[J].Anesth Analg,2006,102(1):8-16.DOI:10.1213/01.ane.0000189614.98906.43.
• [34]Knuuti J,Ballo H,Juarez-Orozco LE,et al.The performance of non-invasive tests to rule-in and rule-out significant coronary artery stenosis in patients with stable angina:a Meta-analysis focused on post-test disease probability[J].Eur Heart J,2018,39(35):3322-3330.DOI:10.1093/eurheartj/ehy267.
• [35]Knuuti J,Wijns W,Saraste A,et al.2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes[J].Eur Heart J,2020,41(3):407-477.DOI:10.1093/eurheartj/ehz425.
• [36]Collet JP,Thiele H,Barbato E,et al.2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation[J].Eur Heart J,2021,42(14):1289-1367.DOI:10.1093/eurheartj/ehaa575.
• [37]Sheth T,Chan M,Butler C,et al.Prognostic capabilities of coronary computed tomographic angiography before non-cardiac surgery:prospective cohort study[J].BMJ,2015,350:h1907.DOI:10.1136/bmj.h1907.
• [38]Vavere AL,Arbab-Zadeh A,Rochitte CE,et al.Coronary artery stenoses:accuracy of 64-detector row CT angiography in segments with mild,moderate,or severe calcification--a subanalysis of the CORE-64 trial[J].Radiology,2011,261(1):100-108.DOI:10.1148/radiol.11110537.
• [39]Zhuang B,Wang S,Zhao S,et al.Computed tomography angiography-derived fractional flow reserve (CT-FFR) for the detection of myocardial ischemia with invasive fractional flow reserve as reference:systematic review and Meta-analysis[J].Eur Radiol,2020,30(2):712-725.DOI:10.1007/s00330-019-06470-8.
• [40]Yang J,Shan D,Wang X,et al.On-site computed tomographyderived fractional flow reserve to guide management of patients with stable coronary artery disease:the TARGET randomized trial[J].Circulation,2023,147(18):1369-1381.DOI:10.1161/CIRCULATIONAHA.123.063996.
• [41]中国医师协会心血管内科医师分会超声心动图和影像学组，《中国介入心脏病学杂志》编辑委员会.冠状动脉CT血流储备分数应用临床路径中国专家共识[J].中国介入心脏病学杂志，2023,31(4):241-251.DOI:10.3969/j.issn.1004-8812.2023.04.001.
• [42]Schulman-Marcus J,Feldman DN,Rao SV,et al.Characteristics of patients undergoing cardiac catheterization before noncardiac surgery:a report from the National Cardiovascular Data Registry Cath PCI Registry[J].JAMA Intern Med,2016,176(5):611-618.DOI:10.1001/jamainternmed.2016.0259.
• [43]Ibanez B,James S,Agewall S,et al.2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation:the task force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC)[J].Eur Heart J,2018,39(2):119-177.DOI:10.1093/eurheartj/ehx393.
• [44]Maron DJ,Hochman JS,Reynolds HR,et al.Initial invasive or conservative strategy for stable coronary disease[J].NEngl J Med,2020,382(15):1395-1407.DOI:10.1056/NEJMoa1915922.
• [45]Bainey KR,Alemayehu W,Welsh RC,et al.Long-term clinical outcomes following revascularization in high-risk coronary anatomy patients with stable ischemic heart disease[J].J Am Heart Assoc,2021,10(1):e018104.DOI:10.1161/JAHA.120.018104.
• [46]Abdallah MS,Wang K,Magnuson EA,et al.Quality of life after surgery or DES in patients with 3-vessel or left main disease[J].JAm Coll Cardiol,2017,69(16):2039-2050.DOI:10.1016/j.jacc.2017.02.031.
• [47]Abdallah MS,Wang K,Magnuson EA,et al.Quality of life after PCI vs.CABG among patients with diabetes and multivessel coronary artery disease:a randomized clinical trial[J].JAMA,2013,310(15):1581-1590.DOI:10.1001/jama.2013.279208.
• [48]Baron SJ,Chinnakondepalli K,Magnuson EA,et al.Quality-of-life after everolimus-eluting stents or bypass surgery for left-main disease:results from the EXCEL trial[J].J Am Coll Cardiol,2017,70(25):3113-3122.DOI:10.1016/j.jacc.2017.10.036.
• [49]Fearon WF,Nishi T,De Bruyne B,et al.Clinical outcomes and cost-effectiveness of fractional flow reserve-guided percutaneous coronary intervention in patients with stable coronary artery disease:three-year follow-up of the FAME 2 trial (fractional flow reserve versus angiography for multivessel evaluation)[J].Circulation,2018,137(5):480-487.DOI:10.1161/CIRCULATIONAHA.117.031907.
• [50]Mc Falls EO,Ward HB,Moritz TE,et al.Coronary-artery revascularization before elective major vascular surgery[J].NEngl J Med,2004,351(27):2795-2804.DOI:10.1056/NEJMoa041905.
• [51]Wong EY,Lawrence HP,Wong DT.The effects of prophylactic coronary revascularization or medical management on patient outcomes after noncardiac surgery--a Meta-analysis[J].Can JAnaesth,2007,54(9):705-717.DOI:10.1007/BF03026867.
• [52]Girardi LN,Rabotnikov Y,Avgerinos DV.Preoperative percutaneous coronary intervention in patients undergoing open thoracoabdominal and descending thoracic aneurysm repair[J].J Thorac Cardiovasc Surg,2014,147(1):163-168.DOI:10.1016/j.jtcvs.2013.09.008.
• [53]Illuminati G,Ricco JB,Greco C,et al.Systematic preoperative coronary angiography and stenting improves postoperative results of carotid endarterectomy in patients with asymptomatic coronary artery disease:a randomised controlled trial[J].Eur J Vasc Endovasc Surg,2010,39(2):139-145.DOI:10.1016/j.ejvs.2009.11.015.
• [54]Windecker S,Neumann FJ,Jüni P,et al.Considerations for the choice between coronary artery bypass grafting and percutaneous coronary intervention as revascularization strategies in major categories of patients with stable multivessel coronary artery disease:an accompanying article of the task force of the 2018 ESC/EACTS guidelines on myocardial revascularization[J].Eur Heart J,2019,40(2):204-212.DOI:10.1093/eurheartj/ehy532.
• [55]Werner GS,Martin-Yuste V,Hildick-Smith D,et al.Arandomized multicentre trial to compare revascularization with optimal medical therapy for the treatment of chronic total coronary occlusions[J].Eur Heart J,2018,39(26):2484-2493.DOI:10.1093/eurheartj/ehy220.
• [56]Neumann FJ,Sousa-Uva M,Ahlsson A,et al.2018 ESC/EACTS Guidelines on myocardial revascularization[J].Euro Intervention,2019,14(14):1435-1534.DOI:10.4244/EIJY19M01_01.
• [57]Richardt G,Abdelghani M,Allali A,et al.Polymer-free drugcoated vs.bare-metal coronary stents in patients undergoing noncardiac surgery:a subgroup analysis of the LEADERS FREEtrial[J].Clin Res Cardiol,2021,110(2):162-171.DOI:10.1007/s00392-020-01672-3.
• [58]宋婷婷，陈韬，荆晶，等.药物涂层球囊在经皮冠状动脉介入治疗中的应用趋势--单中心5年数据分析[J].中国介入心脏病学杂志，2021,29(11):612-616.DOI:10.3969/j.issn.1004-8812.2021.11.003.